Overview and expertises


VIDAL Group is a leading European healthcare informatics and information systems company. With a team of over 200 pharmacists, pharmacologists, physicians, researchers, health informaticists, database architects, and application developers, VIDAL Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information. The VIDAL Group team utilises their collective expertise to provide relevant content from regulatory agencies, drug development organisations and peer-reviewed journals. In order to maximize opportunities for combining information produced by VIDAL Group with other healthcare-related information, VIDAL Group publishes its information using a number of standards relating to the therapeutic use of medications such as the International Classification of Diseases (ICD) and the Anatomical Therapeutic Chemical Classification (ATC). Supporting the information access needs of both patients and providers requires carrying out a number of information sorting, layering, and translation tasks. The collective goal is to provide the consumer-relevant information in a format that facilitates informed, efficient, effective, and economically sensible therapeutic decision-making. It is the consistent and successful accomplishment of these various information-processing tasks that distinguish the VIDAL Group’s medication-centric information products. VIDAL Group solutions are designed for both individual consumption and integration into existing healthcare information-processing systems. The company’s products are currently embedded in over 400 medical software applications in Europe. VIDAL Group is headquartered in Paris. It has local operations in a number of European countries including France, Germany, Portugal and Spain with VIDAL France (Paris) having the largest operation with more than 140 employees. VIDAL Group has recently expanded its sales to Latin America and the Middle East. Corporate Governance